Table 3.
Compound | Scaffold Number | Scaffold Structure | pScorea | inDrugb |
---|---|---|---|---|
JN-KI3 | Scaf1 | 370 | True | |
Scaf2 | 186 | True | ||
Scaf3 | None | False | ||
Scaf4 | None | False |
ADMET Prediction | |||||
Propertiesc | Value | Optimal range | Properties | Value | Optimal range |
CNS | 1 | −2 - +2 | polrz | 51.04 | 13.0–70.0 |
logPC16 | 16.27 | 4.0–18.0 | logPoct | 23.54 | 8.0–35.0 |
logPw | 11.51 | 4.0–45.0 | logPo/w | 5.53 | −2.0–6.5 |
logS | −6.31 | −6.5–0.5 | CIlogS | −6.67 | −6.5–0.5 |
logHERG | −7.53 | concern below −5 | PCaco | 364.52 | <25 poor,>500 great |
logBB | −0.37 | −3.0–1.2 | PMDCK | 453.07 | <25 poor,>500 great |
logKp | −3.08 | −8.0 - −1.0 | logKhsa | 1.05 | −1.5–1.5 |
PHOA | 92.20 | >80% is high<25% is poor | rtvFG | 0 | 0–2 |
pScore values advisory: <100 (low), means no indication; 100–300 (moderate), means weak indication of promiscuity; >300 (high), means strong indication of promiscuity.
inDrug results: true, means it was found in the drug data base; false, means not found.
properties: CNS, predicted central nervous system activity on a −2 (inactive) to + 2 (active) scale; Polrz, predicted polarizability in cubic angstroms; logPC16, predicted hexadecane/gas partition coefficient; logPoct, predicted octanol/gas partition coefficient; logPw, predicted water/gas partition coefficient; logPo/w, predicted octanol/water partition coefficient; logS, predicted aqueous solubility; CIlogS, conformation-independent predicted aqueous solubility; logHERG, predicted IC50 value for blockage of HERG K+ channels; PCaco, predicted apparent Caco-2 cell permeability in nm/sec; logBB, predicted brain/blood partition coefficient; PMDCK, predicted apparent MDCK cell permeability in nm/sec. logKp, predicted skin permeability; logKhsa, prediction of binding to human serum albumin; PHOA, predicted human oral absorption on 0 to 100% scale; rtvFG, Number of reactive functional groups.